Cellular Dynamics Nets $43M in IPO | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics International said on Tuesday that it has closed its initial public offering, raising net proceeds of about $43 million.

The Madison, Wis.-based stem cell technologies firm, which went public last week, said it completed its offering of more than 3.8 million shares of common stock at $12.00 per share. The company trades on the Nasdaq under ticker symbol "ICEL".

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.